The proportionate loss of L-3,4-dihydroxyphenylalanine and L-5-hydroxttryptophan decarboxylating activity in rat central nervous system following intracisternal administration of 5, 6-dihydroxytryptamine or 6-hydroxydopamine.
D006916:5-Hydroxytryptophan; D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001921:Brain / Q000187:drug effects / Q000201:enzymology*; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D002540:Cerebral Cortex / Q000187:drug effects / Q000201:enzymology / Q000502:physiology; D006892:Hydroxydopamines / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology; D010649:Phenylalanine / Q000031:analogs & derivatives; D051381:Rats; D012701:Serotonin / Q000031:analogs & derivatives* / Q000494:pharmacology; D013116:Spinal Cord / Q000187:drug effects / Q000201:enzymology*
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D006892:Hydroxydopamines; D012701:Serotonin; D010649:Phenylalanine; D006916:5-Hydroxytryptophan; D002262:Carboxy-Lyases; D009638:Norepinephrine